Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease [NA]
This completed clinical trial examines donor stem cell transplantation after conditioning therapy in patients with hematologic cancers, recu…
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Homoharringtonine for patients with refractory acute promyelocytic leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients
An observational analysis from a completed study examining voriconazole trough concentrations, pharmacogenomic factors, and clinical outcome…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating the combination of Beta-Glucan and Rituximab in young patients with relapsed or progressive leukemia or lymphoma, i…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow transplantation in advanced hematologic cancers. The tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-03-07Clinical Trial Update: Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [Phase 1]
Phase 1 study evaluating antiviral therapy plus stem cell transplantation in HIV-positive patients with leukemia or lymphoma has been withdr…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of bortezomib combined with vorinostat in high-risk myelodysplastic syndrome or acute myeloid leukemia has been terminated; re…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Melphalan in Patients With Neoplastic Meningitis [Phase 1]
Phase 1 trial of intrathecal melphalan in patients with neoplastic meningitis has completed.
-
CLINICAL_TRIALS research · 2013-02-20Clinical Trial Update: Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating infusion of donor-derived natural killer cells after donor stem cell transplant for various …
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [Phase 1]
A Phase 1 trial evaluating decitabine in melanoma and other advanced cancers has completed. The study explored safety and dosing across hema…
-
CLINICAL_TRIALS withdrawal · 2013-02-15Clinical Trial Update: Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies [Phase 1, Phase 2]
Clinical trial update notes the withdrawal of a Phase 1/2 study evaluating antimicrobial versus saline solutions to maintain catheter patenc…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without monoclonal antibody therapy in leukemia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Tipifarnib in Treating Patients With Advanced Hematologic Cancer [Phase 1]
This document reports the status of a Phase 1 clinical trial of tipifarnib for advanced hematologic cancers sponsored by the National Cancer…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders [Phase 1]
Phase 1 study assessing decitabine with FR901228 (romidepsin) in patients with relapsed or refractory leukemia, myelodysplastic syndromes, a…
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [Phase 1, Phase 2]
This clinical trial update indicates termination of a Phase 1/2 study evaluating arsenic trioxide with or without tretinoin in patients with…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia [Phase 2]
Phase 2 clinical trial update of combination chemotherapy followed by peripheral stem cell transplantation and interleukin-2 in acute leukem…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia [Phase 1]
This Phase 1 trial update reports completion of a chemotherapy regimen in combination with PSC-833 (valspodar) for children with refractory …
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Topotecan in Treating Children With Refractory Leukemia [Phase 1]
A Phase 1 clinical trial evaluating Topotecan in children with refractory leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 clinical study evaluating sequential administration of Interleukin-12 followed by Interferon alfa in adults with advanced cancer; th…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating thalidomide for anemia in patients with myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: FR901228 in Treating Patients With Hematologic Cancer [Phase 1]
This Phase 1 trial update reports the completion of a study of FR901228 in patients with hematologic cancers, including leukemia and lymphom…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]
A Phase 1/2 study evaluated the safety and preliminary efficacy of combining amifostine with topotecan in patients with leukemia and myelody…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer [Phase 3]
Phase 3 trial evaluating whether St. John's Wort can relieve fatigue in cancer patients undergoing chemotherapy or hormone therapy has compl…
-
EMA withdrawal · 2013-01-18EMA Application withdrawn: Loulla — Only For Children Pharmaceuticals
The EMA withdrew the application for Loulla from Only For Children Pharmaceuticals for a leukemia/lymphoid therapeutic area.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update evaluating a vaccine therapy for patients with myelodysplastic syndromes. The conditions list also includes le…